{"id":3693,"date":"2021-01-20T14:01:45","date_gmt":"2021-01-20T13:01:45","guid":{"rendered":"https:\/\/glycanostics.com\/?p=3693"},"modified":"2026-07-27T14:22:16","modified_gmt":"2026-07-27T12:22:16","slug":"eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021","status":"publish","type":"post","link":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/","title":{"rendered":"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021"},"content":{"rendered":"<p>Je pre n\u00e1s ve\u013ek\u00fdm pote\u0161en\u00edm ozn\u00e1mi\u0165, \u017ee Eva Kov\u00e1\u010dov\u00e1 prijala na\u0161u ponuku a stala sa na\u0161ou novou CEO od janu\u00e1ra 2021. Eva pracovala viac ne\u017e 18 rokov na r\u00f4znych riadiacich poz\u00edci\u00e1ch pre najv\u00e4\u010d\u0161ie farmaceutick\u00e9 spolo\u010dnosti v oblasti f\u00fazi\u00ed a akviz\u00edci\u00ed, ako aj finan\u010dn\u00e9ho riadenia. Bola s\u00fa\u010das\u0165ou t\u00edmu, ktor\u00fd zabezpe\u010dil podpis trojramennej zmluvy medzi spolo\u010dnos\u0165ami GSK a Novartis v apr\u00edli 2014, na z\u00e1klade ktorej spolo\u010dnos\u0165 GSK z\u00edskala od Novartisu ich glob\u00e1lne portf\u00f3lio vakc\u00edn v hodnote\u00a0 5.25 miliardy USD, predala Novartisu svoje portf\u00f3lio onkologick\u00fdch liekov v hodnote 16 mili\u00e1rd USD a spolo\u010dne sa dohodli na zriaden\u00ed spolo\u010dn\u00e9ho podniku (joint venture) pre ich kombinovan\u00e9 portf\u00f3lio vo\u013enopredajn\u00fdch liekov s o\u010dak\u00e1van\u00fdmi v\u00fdnosmi vo v\u00fd\u0161ke 6,5 mili\u00e1rd USD. Nesk\u00f4r viedla integra\u010dn\u00fd proces pre cel\u00fd regi\u00f3n EMEA a Latinskej Ameriky, na z\u00e1klade ktor\u00e9ho vznikol spolo\u010dn\u00fd podnik medzi GSK a Novartis a nesk\u00f4r aj medzi GSK a Pfizer, s o\u010dak\u00e1van\u00fdmi v\u00fdnosmi 10 mili\u00e1rd USD (nesk\u00f4r uveden\u00fd na burzu NYSE a LSE pod menom Haleon). Taktie\u017e viedla projekt od\u010dlenenia div\u00edzie LifeScan od spolo\u010dnosti Johnson &amp; Johnson pre cel\u00fd regi\u00f3n EMEA v hodnote 2 mili\u00e1rd EUR. Eva prin\u00e1\u0161a do Glycanostics jej sk\u00fasenosti z r\u00f4znych oddelen\u00ed farmaceutick\u00fdch spolo\u010dnost\u00ed, ako aj sk\u00fasenosti z oblasti rozvoja biznisu a strategick\u00e9ho riadenia.<\/p>\n<p>Te\u0161\u00edme sa, \u017ee budeme spolo\u010dne vytv\u00e1ra\u0165 vysoko profesion\u00e1lnu spolo\u010dnos\u0165, pri\u0165ahova\u0165 k\u013e\u00fa\u010dov\u00e9 talenty a \u017ee si z\u00edskame d\u00f4veru investorov, ako aj grantov\u00fdch agent\u00far.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Je pre n\u00e1s ve\u013ek\u00fdm pote\u0161en\u00edm ozn\u00e1mi\u0165, \u017ee Eva Kov\u00e1\u010dov\u00e1 prijala na\u0161u ponuku a stala sa na\u0161ou novou CEO od janu\u00e1ra 2021. Eva pracovala viac ne\u017e 18 rokov na r\u00f4znych riadiacich poz\u00edci\u00e1ch pre najv\u00e4\u010d\u0161ie farmaceutick\u00e9 spolo\u010dnosti v oblasti f\u00fazi\u00ed a akviz\u00edci\u00ed, ako aj finan\u010dn\u00e9ho riadenia. Bola s\u00fa\u010das\u0165ou t\u00edmu, ktor\u00fd zabezpe\u010dil podpis trojramennej zmluvy medzi spolo\u010dnos\u0165ami GSK [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":3694,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[23,14],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021 - Glycanostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021 - Glycanostics\" \/>\n<meta property=\"og:description\" content=\"Je pre n\u00e1s ve\u013ek\u00fdm pote\u0161en\u00edm ozn\u00e1mi\u0165, \u017ee Eva Kov\u00e1\u010dov\u00e1 prijala na\u0161u ponuku a stala sa na\u0161ou novou CEO od janu\u00e1ra 2021. Eva pracovala viac ne\u017e 18 rokov na r\u00f4znych riadiacich poz\u00edci\u00e1ch pre najv\u00e4\u010d\u0161ie farmaceutick\u00e9 spolo\u010dnosti v oblasti f\u00fazi\u00ed a akviz\u00edci\u00ed, ako aj finan\u010dn\u00e9ho riadenia. Bola s\u00fa\u010das\u0165ou t\u00edmu, ktor\u00fd zabezpe\u010dil podpis trojramennej zmluvy medzi spolo\u010dnos\u0165ami GSK [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Glycanostics\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T13:01:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-27T12:22:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/glycanostics.com\/wp-content\/uploads\/2026\/07\/Eva-Kovacova.png\" \/>\n\t<meta property=\"og:image:width\" content=\"264\" \/>\n\t<meta property=\"og:image:height\" content=\"263\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Silvia Valcuhova\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silvia Valcuhova\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 min\u00fata\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/\",\"url\":\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/\",\"name\":\"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021 - Glycanostics\",\"isPartOf\":{\"@id\":\"https:\/\/glycanostics.com\/#website\"},\"datePublished\":\"2021-01-20T13:01:45+00:00\",\"dateModified\":\"2026-07-27T12:22:16+00:00\",\"author\":{\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/ef445d02c9d2875b7e18867de7d890dc\"},\"breadcrumb\":{\"@id\":\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glycanostics.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glycanostics.com\/#website\",\"url\":\"https:\/\/glycanostics.com\/\",\"name\":\"Glycanostics\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glycanostics.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/ef445d02c9d2875b7e18867de7d890dc\",\"name\":\"Silvia Valcuhova\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e71275db8660b282e0d848089c16fc46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e71275db8660b282e0d848089c16fc46?s=96&d=mm&r=g\",\"caption\":\"Silvia Valcuhova\"},\"url\":\"https:\/\/glycanostics.com\/sk\/author\/silvia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021 - Glycanostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/","og_locale":"sk_SK","og_type":"article","og_title":"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021 - Glycanostics","og_description":"Je pre n\u00e1s ve\u013ek\u00fdm pote\u0161en\u00edm ozn\u00e1mi\u0165, \u017ee Eva Kov\u00e1\u010dov\u00e1 prijala na\u0161u ponuku a stala sa na\u0161ou novou CEO od janu\u00e1ra 2021. Eva pracovala viac ne\u017e 18 rokov na r\u00f4znych riadiacich poz\u00edci\u00e1ch pre najv\u00e4\u010d\u0161ie farmaceutick\u00e9 spolo\u010dnosti v oblasti f\u00fazi\u00ed a akviz\u00edci\u00ed, ako aj finan\u010dn\u00e9ho riadenia. Bola s\u00fa\u010das\u0165ou t\u00edmu, ktor\u00fd zabezpe\u010dil podpis trojramennej zmluvy medzi spolo\u010dnos\u0165ami GSK [&hellip;]","og_url":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/","og_site_name":"Glycanostics","article_published_time":"2021-01-20T13:01:45+00:00","article_modified_time":"2026-07-27T12:22:16+00:00","og_image":[{"width":264,"height":263,"url":"https:\/\/glycanostics.com\/wp-content\/uploads\/2026\/07\/Eva-Kovacova.png","type":"image\/png"}],"author":"Silvia Valcuhova","twitter_card":"summary_large_image","twitter_misc":{"Autor":"Silvia Valcuhova","Predpokladan\u00fd \u010das \u010d\u00edtania":"1 min\u00fata"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/","url":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/","name":"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021 - Glycanostics","isPartOf":{"@id":"https:\/\/glycanostics.com\/#website"},"datePublished":"2021-01-20T13:01:45+00:00","dateModified":"2026-07-27T12:22:16+00:00","author":{"@id":"https:\/\/glycanostics.com\/#\/schema\/person\/ef445d02c9d2875b7e18867de7d890dc"},"breadcrumb":{"@id":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/glycanostics.com\/sk\/eva-kovacova-sa-stava-novou-ceo-glycanostics-od-januara-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glycanostics.com\/"},{"@type":"ListItem","position":2,"name":"Eva Kov\u00e1\u010dov\u00e1 sa st\u00e1va novou CEO Glycanostics od janu\u00e1ra 2021"}]},{"@type":"WebSite","@id":"https:\/\/glycanostics.com\/#website","url":"https:\/\/glycanostics.com\/","name":"Glycanostics","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glycanostics.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/ef445d02c9d2875b7e18867de7d890dc","name":"Silvia Valcuhova","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e71275db8660b282e0d848089c16fc46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e71275db8660b282e0d848089c16fc46?s=96&d=mm&r=g","caption":"Silvia Valcuhova"},"url":"https:\/\/glycanostics.com\/sk\/author\/silvia\/"}]}},"_links":{"self":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/3693"}],"collection":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/comments?post=3693"}],"version-history":[{"count":1,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/3693\/revisions"}],"predecessor-version":[{"id":3696,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/3693\/revisions\/3696"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/media\/3694"}],"wp:attachment":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/media?parent=3693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/categories?post=3693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/tags?post=3693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}